Get started
Author

Dinesh Khullar

Observed names: D Khullar, D. Khullar, Dr Dinesh Khullar
Observed institutions: Apollo Hospitals, Christian Medical College, Vellore, King Edward Memorial Hospital and Seth G.S. Medical College, P. D. Hinduja Hospital and Medical Research Centre, Jaslok Hospital, Max Super Speciality Hospital, CARE Hospitals, Max Healthcare, Dayanand Medical College & Hospital, Rabindranath Tagore International Institute of Cardiac Sciences, Astellas Pharma (India), Christian Medical College, The George Institute for Global Health, Sir Ganga Ram Hospital, Apollo Hospitals, Devki Devi Foundation, University College London, Post Graduate Institute of Medical Education and Research
ORCID: 0000-0003-4276-2575
Observed ORCID: 0000-0003-4276-2575
OpenAlex ID: A5035771017
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
2019 · Hiddo J L Heerspink, Bergur V Stefansson, et al. · Nephrology Dialysis Transplantation · 225
PDF
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
2020 · David C Wheeler, Bergur V Stefansson, et al. · Nephrology Dialysis Transplantation · 199
PDF
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
2021 · Zien Zhou, Meg J. Jardine, et al. · Stroke · 128
PDF
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
2021 · Hiddo J L Heerspink, C David Sjöström, et al. · European Heart Journal · 128
PDF
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
2024 · Hiddo J L Heerspink, Rajiv Agarwal, et al. · Nephrology Dialysis Transplantation · 109
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
2021 · Hiddo J.L. Heerspink, David Cherney, et al. · Kidney International · 99
PDF
Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis
2009 · Ambar Khaira, Ankur Gupta, et al. · International Urology and Nephrology · 90
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study
2025 · David Kavanagh, Andrew S Bomback, et al. · The Lancet · 70
PDF
Acute Kidney Injury Risk Assessment: Differences and Similarities Between Resource-Limited and Resource-Rich Countries
2017 · Kianoush Kashani, Etienne Macedo, et al. · Kidney International Reports · 49
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
2023 · Tae Won Yi, Brendan Smyth, et al. · American Journal of Kidney Diseases · 37
PDF
Pulmonary mucormycosis presenting as fatal massive haemoptysis in a renal transplant recipient
1998 · K. Gupta, D. Khullar, et al. · Nephrology Dialysis Transplantation · 37
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics
2025 · Rajiv Agarwal, Jennifer B Green, et al. · Nephrology Dialysis Transplantation · 35
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex
2023 · Margaret K. Yu, Priya Vart, et al. · Journal of General Internal Medicine · 33
PDF
Prospective Nonrandomized Comparison Between Open and Robot-Assisted Kidney Transplantation: Analysis of Midterm Functional Outcomes
2020 · R. Maheshwari, S.Y. Qadri, et al. · Journal of Endourology · 25
A Multicenter Cohort Study From India of 75 Kidney Transplants in Recipients Recovered After COVID-19
2021 · Vivek B. Kute, Deepak S. Ray, et al. · Transplantation · 21
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial
2026 · Brendon L. Neuen, Vlado Perkovic, et al. · JAMA · 18
PDF
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions
2022 · Priya Vart, Ricardo Correa-Rotter, et al. · Kidney International Reports · 16
PDF
Acute Renal Failure in a Patient with HELLP Syndrome—An Unusual Complication of Eclampsia
1994 · A. K. Ghosh, K. Vashisht, et al. · Renal Failure · 14
Analysis of kidney and liver exchange transplantation in India (2000–2025): a multicentre, retrospective cohort study
2025 · Vivek B. Kute, Himanshu V. Patel, et al. · The Lancet Regional Health - Southeast Asia · 12
PDF
Finerenone: Will It Be a Game-changer?
2024 · Dinesh Khullar, Anish Kumar Gupta, et al. · Cardiac failure review · 12
PDF
C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation
2024 · Karin Heidenreich, Deepti Goel, et al. · Frontiers in Nephrology · 12
PDF
Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian Indian patients of ADPKD
2019 · Shewata Pandita, Vijaya Ramachandran, et al. · Journal of Human Genetics · 12
Management Strategies and Outcomes in Renal Transplant Recipients Recovering from COVID-19: A Retrospective, Multicentre Study
2022 · Vivek B. Kute, Deepak S. Ray, et al. · EClinicalMedicine · 10
PDF
The Effect of Bariatric Surgery on Patients with Chronic Kidney Disease
2020 · Pallavi Prasad, Dinesh Khullar, et al. · Obesity Surgery · 9
Autosomal dominant polycystic kidney disease: Presence of hypomorphic alleles in PKD1 Gene
2018 · S Pandita, D Khullar, et al. · Indian Journal of Nephrology · 8
Works count: 131
Citation count: 1,559
H-index: 16
I10-index: 23
Year
Topic
Type